Comparison between Akums Drugs IPO and Vraj Iron IPO.
Akums Drugs IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Vraj Iron IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Akums Drugs IPO is up to ₹1,856.74 Cr whereas the issue size of the Vraj Iron IPO is up to ₹171.00 Cr. The final issue price of Akums Drugs IPO is ₹679.00 per share and of Vraj Iron IPO is ₹207.00 per share.
| Akums Drugs IPO | Vraj Iron IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹10 per share |
| Issue Price (Lower) | ₹646.00 per share | ₹195.00 per share |
| Issue Price (Upper) | ₹679.00 per share | ₹207.00 per share |
| Issue Price (Final) | ₹679.00 per share | ₹207.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹64.00 per share | |
| Market Lot Size | 22 shares | 72 shares |
| Fresh Issue Size | 1,00,37,708 shares | 82,60,869 shares |
| Fresh Issue Size (Amount) | up to ₹680.99 Cr | up to ₹171.00 Cr |
| OFS Issue Size | 1,73,30,435 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹1,175.75 Cr | up to ₹0.00 Cr |
| Issue Size Total | 2,73,68,143 shares | 82,60,869 shares |
| Issue Size Total (Amount) | up to ₹1,856.74 Cr | up to ₹171.00 Cr |
Akums Drugs IPO opens on Jul 30, 2024, while Vraj Iron IPO opens on Jun 26, 2024. The closing date of Akums Drugs IPO and Vraj Iron IPO is Aug 01, 2024, and Jun 28, 2024, respectively.
| Akums Drugs IPO | Vraj Iron IPO | |
|---|---|---|
| Anchor Bid Date | Jul 29, 2024 | Jun 25, 2024 |
| Issue Open | Jul 30, 2024 | Jun 26, 2024 |
| Issue Close | Aug 01, 2024 | Jun 28, 2024 |
| Basis Of Allotment (Tentative) | Aug 02, 2024 | Jul 01, 2024 |
| Initiation of Refunds (Tentative) | Aug 05, 2024 | Jul 02, 2024 |
| Credit of Share (Tentative) | Aug 05, 2024 | Jul 02, 2024 |
| Listing date (Tentative) | Aug 06, 2024 | Jul 03, 2024 |
| Anchor Lockin End date 1 | Sep 01, 2024 | Jul 31, 2024 |
| Anchor Lockin End date 2 | Oct 31, 2024 | Sep 29, 2024 |
Akums Drugs IPO P/E ratio is , as compared to Vraj Iron IPO P/E ratio of 9.48.
| Akums Drugs IPO | Vraj Iron IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 82.48 | 99.99 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 75.29 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 9.48 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹682.74 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 0.11% | 23.78% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 3.37% | 25.34% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.69 | 0.27 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹21.84 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | -0.57 | 23.78% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Akums Drugs IPO Retail Individual Investors (RII) are offered 27,12,424 shares while in Vraj Iron IPO retail investors are offered 27,12,424 shares. Qualified Institutional Buyers (QIB) are offered 81,37,276 shares in Akums Drugs IPO and 16,52,174 shares in Vraj Iron IPO.
| Akums Drugs IPO | Vraj Iron IPO | |
|---|---|---|
| Anchor Investor Reservation | 1,22,05,912 shares | 24,78,259 shares |
| Market Maker Reservation | ||
| QIB | 81,37,276 shares | 16,52,174 shares |
| NII | 40,68,637 shares | 12,39,131 shares |
| RII | 27,12,424 shares | 28,91,305 shares |
| Employee | 2,43,902 shares | |
| Others | ||
| Total | 2,73,68,151 shares | 82,60,869 shares |
Akums Drugs IPO subscribed 63.44x in total, whereas Vraj Iron IPO subscribed 126.36x.
| Akums Drugs IPO | Vraj Iron IPO | |
|---|---|---|
| QIB (times) | 90.09x | 173.99x |
| NII (times) | 42.10x | 221.66x |
| Big NII (times) | 47.43x | 217.50x |
| Small NII (times) | 31.45x | 229.99x |
| RII (times) | 20.80x | 58.31x |
| Employee (times) | 4.14x | |
| Other (times) | ||
| Total (times) | 63.44x | 126.36x |
